A pharmaceutical composition comprising an exendin-4 peptide comprising the amino acid sequence HGEGTFTSDL SKQMEEEAVR LFIEWLKNGG PSSGAPPPS in an amount from 0.001 mg to 1 mg based on a 70 kg patient; a pharmaceutically acceptable buffer; a pharmaceutically acceptable isotonicity agent; and a pharmaceutically acceptable carrier.